NCT00463346View on ClinicalTrials.gov

Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism

PHASE3CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Alcohol DependenceSchizophrenia

Interventions

DRUG

Acamprosate

Acamprosate 1998 mg tid

DRUG

Placebo

Placebo

Trial Locations (1)

06516

VA Connecticut Healthcare System, West Haven

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Yale University

OTHER